EAS-heartwire Newsfeed

This feature on the EAS website is brought to you in collaboration with MedScape and theHeart.org.The feed is specifically tailored to the interests of EAS members. The articles listed below have been selected for their relevance to atherosclerosis and related topics, and are updated regularly.

AV nodal ablation ups survival in AF patients with CRT
Wed, 22 Feb 2012 09:45:57 EST

Catheter ablation also seemed to improve NYHA functional class, but not contractile function, in patients with atrial fibrillation receiving device therapy for heart failure.


Is new gene analysis the final chapter in the homocysteine saga?
Tue, 21 Feb 2012 17:00:00 EST

An international group of distinguished researchers says newly examined, unpublished genetic data provide final proof that homocysteine does not cause coronary heart disease and therefore reducing levels of this amino acid with folate would have no effect. But another expert disagrees.


Young women with MI most likely to have no chest pain
Tue, 21 Feb 2012 16:00:00 EST

A new analysis of the NRMI registry also finds that women under 55 have the highest risk of death after MI.


Detailed family history improves cardiovascular disease risk assessment
Mon, 20 Feb 2012 17:00:00 EST

Compared with clinical practices that used traditional risk-assessment models, the systematic collection of a family history identified an additional 5% at high cardiovascular disease risk, according to researchers.


Pregnancy complications up CVD risk by 30%
Mon, 20 Feb 2012 10:15:00 EST

A new study is helping to tease out the contributions of different pregnancy complications to future CVD risk in women; the results show that the mechanisms linking each condition to CV risk likely differ.


EMA: New aliskiren restrictions and decisions on aprotinin, orlistat
Fri, 17 Feb 2012 17:00:13 EST

The European Medicines Agency's Committee for Medicinal Products for Human Use recommended lifting the suspension on aprotinin, adding new warnings on aliskiren products, and supporting orlistat for some patients, among other opinions issued at its February meeting.


Ten-month Medicare "doc fix" passes Congress, heads for White House
Fri, 17 Feb 2012 13:30:22 EST

Although it averts a 27.4% Medicare pay cut for physicians set for March 1, the latest doc fix seems to leave everyone unhappy, especially physicians.


Mutations in giant gene a major cause of familial DCM
Fri, 17 Feb 2012 09:45:51 EST

They probably account for more than a fifth of idiopathic dilated-cardiomyopathy cases, say researchers, pioneers of genetic variation in a massive protein that is a major player in myocardial contraction.


CardioGen-82 returns to market
Thu, 16 Feb 2012 16:15:21 EST

For its return, the FDA-approved revised labeling for CardioGen-82 includes a new boxed warning. The label warns of unintended radiation exposure when levels of Sr-82 and Sr-85 in the rubidium Rb-82 chloride injection exceed limits.


Exercise, regardless of amount of sedentary time, improves risk factors in kids
Wed, 15 Feb 2012 16:45:19 EST

Researchers say that children should be encouraged to increase their participation in moderate to vigorous physical activity rather than decrease the amount of time they spend sedentary, as this appears more important in relation to cardiometabolic health.


New ACCP thrombosis guidelines offer weak support for aspirin in primary prevention �
Wed, 15 Feb 2012 15:00:21 EST

UPDATED // In a new development, the guidelines committee was headed by clinicians who specialized in interpretation of clinical trials rather than opinion leaders in the antithrombotic field, which has led to less strong recommendations for antithrombotic therapy than before.


Short-term exposure to air pollutants ups MI risk: Meta-analysis
Wed, 15 Feb 2012 10:00:56 EST

Of six individual air pollutants, only one didn't seem to raise the risk of MI at exposures of up to a week, according to a meta-analysis.


Vitamin D in CKD: No benefit for CV function, structure
Tue, 14 Feb 2012 16:00:00 EST

The findings are important, given the prevalence of vitamin-D deficiency in this group of patients, researchers say.


Cardiac stem-cells increase viable myocardium post-MI: CADUCEUS
Mon, 13 Feb 2012 18:30:00 EST

Researchers and other experts in the field of cardiac regeneration research are excited by the small, phase 1 study, which showed scar to be reduced on cardiac imaging at the same time that viable myocardial mass was increasing, over six and 12 months.


No cancer protection with vitamin B or omega-3 fatty-acid supplements
Mon, 13 Feb 2012 16:00:00 EST

The investigators did observe a statistically significant interaction by sex, however, with women taking omega-3 fatty acids at an increased for cancer. They caution, however, that the results might be due to chance, given the few cancer cases and cancer deaths that occurred in women treated with the supplements.


More doctors advising patients to exercise
Fri, 10 Feb 2012 14:45:43 EST

In 2010, one in three patients who visited a physician or other health professional had been told to start or maintain physical activity or exercise.


More hope for factor Xa reversal
Fri, 10 Feb 2012 14:00:30 EST

A new study has suggested that the anticoagulant effects of edoxaban could be reversed by several hemostatic agents currently used to control excessive bleeding in other situations.


The doctor will see you now (from the other side of the world)
Fri, 10 Feb 2012 12:30:18 EST

A unique "medical mission" using handheld echo in a remote rural population in India is being hailed as a success after cardiologists around the globe logged on over a two-day period to read the echocardiograms of unseen patients half a world away.


US judge upholds FDA approval of generic enoxaparin
Thu, 09 Feb 2012 16:30:13 EST

Sanofi-Aventis had sued the agency in 2010, saying it had failed to follow its own rules and had not appropriately established that a generic drug made by a rival company included the same active ingredient as Lovenox.


Over 1300 deaths in Mediator scandal in France
Thu, 09 Feb 2012 14:15:48 EST

The number of deaths attributable to heart-valve insufficiency as a result of the use of benfluorex in France is likely more than double that previously thought, a new investigation finds.


Ten foods provide half of sodium eaten in US
Thu, 09 Feb 2012 10:00:06 EST

New estimates of salt consumption from a recent US survey show that 10 food groups provide almost half of the dietary sodium consumed in the country and that 90% of individuals eat more than the recommended daily amount of sodium.


Like father, like son: Y-chromosome variant may explain CAD
Wed, 08 Feb 2012 18:30:00 EST

New genetic work has unveiled an association between some lineages of the relatively empty male Y chromosome and coronary artery disease. The hypothesis, while "intriguing," requires more research to confirm, says one expert.


For stroke risk, look for novel lipid/lipoprotein biomarkers
Wed, 08 Feb 2012 11:15:16 EST

Women with triglyceride levels in the highest quartile had a significant 56% increased risk of stroke compared with women in the lowest quartile. Similarly, for women with highest quartile of VLDL particle size and IDL particle number, there was a significant 59% and 46% increased risk of ischemic stroke compared with women in the lowest quartile.


SWITCH III: Bivalirudin is as safe as heparin after fondaparinux in PCI patients
Tue, 07 Feb 2012 12:30:10 EST

Recent studies have shown that ACS patients on fondaparinux prior to PCI should switch to another anticoagulant prior to the procedure to avoid thrombus. The SWITCH III trial compares bivalirudin and unfractionated heparin in a small group of these patients.


Fitness and fatness independently linked with CVD risk factors
Mon, 06 Feb 2012 16:00:00 EST

Individuals should be aware that exercising can have positive health effects, even if the weight doesn't necessarily come off, as can losing weight alone, researchers say, although the ideal combination is to improve fitness and lose fat.


MI-shock proposal is cold comfort: Hypothermia might boost survival
Mon, 06 Feb 2012 16:00:00 EST

Some data suggest therapeutic hypothermia might reduce the currently high mortality from cardiogenic shock; let's do the necessary clinical studies to see whether it might be true, urges a published viewpoint.


Lower mortality in NFL players�if weight is kept in check
Mon, 06 Feb 2012 14:15:21 EST

The reduction in mortality and cardiovascular disease was observed in the smaller players—defensive backs, quarterbacks, and wide receivers, as well as fullbacks, halfbacks, and running backs, among others. For the true giants of the gridiron, the linemen, cardiovascular disease mortality was not significantly reduced compared with the US population.


KEEP: Focus on CKD patients with highest SBP
Mon, 06 Feb 2012 12:30:06 EST

A new, contemporary study in real-world patients with chronic kidney disease finds that those with systolic BPs of 140 mm Hg and higher are at the greatest risk of developing end-stage renal disease. Hence the current "goal" in CKD patients of 130 mm Hg should be revised upward, say the authors, making the target easier to achieve and allowing physicians to focus on other aspects of care.


"Irrational" choices stall adoption of new antiplatelets
Mon, 06 Feb 2012 09:15:50 EST

Dr David Cohen points out some of physicians' potential "psychological" barriers to more rapid adoption of new antiplatelet agents, even though they may be the best choice for their patients.


Sitagliptin/metformin once-daily combo approved for diabetes
Fri, 03 Feb 2012 18:00:59 EST

The extended-release combination of sitagliptin and metformin joins saxagliptin/metformin as a once-daily tablet for type 2 diabetes.